3654 results for «444»
3654 results
Artificial intelligence and advanced imaging in coronary interventions
19 May 2026 – From EuroPCR 2026
This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...
STEMI presenting with cardiogenic shock
19 May 2026 – From EuroPCR 2026
This session covers acute management of STEMI presenting with cardiogenic shock, illustrating advanced interventional strategies and support devices such as ECMO, IABP, and Impella. It reviews complex clinical scenarios including acute left main occlusion and multivessel disease, offering critical insights into emergent care and decision-making.
Stent failure evaluation with intracoronary imaging
19 May 2026 – From EuroPCR 2026
This session provides an in-depth evaluation of stent failure using intracoronary imaging modalities such as IVUS and OCT. It presents diverse cases illustrating late drug-eluting stent failure, in-stent restenosis, neoatherosclerosis, and complications following rotational atherectomy, underscoring imaging's role in diagnosis and guiding reintervention.
Leaflet modification techniques during TAVI
19 May 2026 – From EuroPCR 2026
This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.
Transcatheter mitral valve replacement - LIVE case
20 May 2026 – From EuroPCR 2026
A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).
A transcatheter mitral...
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices
20 May 2026 – From EuroPCR 2026
This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System
15 Feb 2022
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
08 Nov 2022
Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.
Author
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.
Author
The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study
03 Nov 2025
Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.
Author
Author
